| Filed On | Filing |
|---|---|
| 17 Sep 2026 |
Form 4: Heffernan Michael Thomas, Director
Received 39,473 shares by exercise or conversion ($126K) · Sold 39,473 shares ($596K) |
| 15 Sep 2026 | 144 |
| 06 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | S-8 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 04 Jun 2026 |
Form 4: Mathers Edward T, Director
Granted 35,000 Nonstatutory Stock Option (right to buy) |
| 04 Jun 2026 |
Form 4: Colangelo Dominick, Director
Granted 35,000 Nonstatutory Stock Option (right to buy) |
| 04 Jun 2026 |
Form 4: Meeker David P, Director
Granted 35,000 Nonstatutory Stock Option (right to buy) |
| 04 Jun 2026 |
Form 4: Vanlent Anne, Director
Granted 35,000 Nonstatutory Stock Option (right to buy) |
| 04 Jun 2026 |
Form 4: Heffernan Michael Thomas, Director
Granted 35,000 Nonstatutory Stock Option (right to buy) |
| 04 Jun 2026 | 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders |
| 07 May 2026 | SCHEDULE 13D/A |
| 06 May 2026 | SCHEDULE 13G/A |
| 05 May 2026 | 10-Q |
| 05 May 2026 | 8-K: Results of Operations and Financial Condition |
| 21 Apr 2026 | ARS |
| 21 Apr 2026 |
Proxy statement: annual meeting on June 3, 2026
CEO pay $3.9M, up 52% · say-on-pay vote |
| 21 Apr 2026 | DEFA14A |
| 17 Apr 2026 | 424B5 |
Loading...
